Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

NCT05244239 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05244239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05244239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Recruiting
Start date
July 27, 2022
Completion date
July 28, 2027
Enrollment
22 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage lung small cell carcinoma, stage iv lung cancer ajcc v8